Title
Category
Credits
Event date
Cost
  • Disease management
  • 1.25 ACPE - Pharmacists
  • 1.25 ACPE - Pharmacy Technicians
  • 1.25 AMA - Physicians
  • 1.25 ANCC - Nurses
  • 1.25 APA - Psychologists
  • 1.25 Attendance - General Attendance
  • 1.25 ASWB - Social Workers
$0.00
This session explores the latest updates in the diagnosis and management of chronic obstructive pulmonary disease (COPD) as outlined in the 2025 GOLD Report. Early case finding, refined spirometry protocols and novel therapeutic options are discussed, along with the importance of pre-bronchodilator spirometry, strategies for early detection in at-risk populations, and the integration of new treatments into updated treatment algorithms.
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 ASWB - Social Workers
$0.00
Dementia care poses growing challenges in health care, requiring early recognition, accurate diagnosis, and compassionate, evidence-based care. This activity clarifies distinctions between dementia and mild cognitive impairment, reviews common subtypes, and highlights core strategies for improving care delivery and enhancing support for patients and caregivers.
  • Disease management
  • Transplantation
  • 1.25 ACPE - Pharmacists
  • 1.25 ACPE - Pharmacy Technicians
  • 1.25 AMA - Physicians
  • 1.25 ANCC - Nurses
  • 1.25 APA - Psychologists
  • 1.25 Attendance - General Attendance
  • 1.25 ASWB - Social Workers
$0.00
This presentation reviews the latest evidence-based strategies for identifying, diagnosing and managing non-alcoholic fatty liver disease (NAFLD), now recognized as metabolic dysfunction-associated steatotic liver disease (MASLD). The progressive form of this disease, non-alcoholic steatohepatitis (NASH), is on track to become the leading cause of liver transplantation in the United States. Learn about current guidelines, risk-stratification tools, and emerging therapies, and gain insights to improve early detection and optimize patient outcomes.
  • Vision
  • 1.00 Attendance - General Attendance
  • 1.00 COPE - Optometrists
$0.00
This activity will provide an overview of the multiple subtypes of ARMD, including dry, intermediate, and wet ARMD, and geographic atrophy. It will explore existing and emerging therapies for ARMD subtypes, as well as their efficacy and safety profiles. In addition, testing strategies that can help determine the direction of ARMD management plans, as well as applications and programs for low-vision care, will be identified.
  • Cardiology
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
This on-demand webcast aims to equip primary care providers with the knowledge and tools necessary for the early identification and management of atrial fibrillation (AFib). Participants will review the epidemiology and risk factors associated with AFib, explore the clinical decision-making process for rate versus rhythm control, and apply current evidence-based guidelines for stroke prevention. Emphasis will be placed on practical approaches to risk stratification, shared decision-making, and optimizing long-term outcomes in the primary care setting.
  • Disease management
  • Older adults
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
Activity descriptionThis on-demand webcast will explore the scope and impact of urinary tract infections (UTIs) in long-term care (LTC) settings, including prevalence, costs and clinical challenges. Participants will learn to differentiate UTIs from asymptomatic bacteriuria, apply evidence-based diagnostic criteria and implement strategies for prevention and treatment. Hydration practices, catheter maintenance and risk reduction to improve resident outcomes and reduce unnecessary antibiotic use will also be discussed.
  • Disease management
  • Older adults
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
Activity descriptionThis activity will introduce the concept of diagnostic stewardship, emphasizing how appropriate test selection impacts patient care. Learners will explore the phases of diagnostic stewardship — pre-analytic, analytic and post-analytic — and learn the importance of pre-test probability in guiding test decisions. Real-world examples will illustrate common pitfalls and best practices in ordering diagnostic tests.
  • Disease management
  • Older adults
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
Activity descriptionThis activity focuses on the complexities of managing patients in long-term care settings who present with multiple competing comorbidities. Participants will examine key take-home points for each major condition and reinforce the application of guideline-directed medical therapy (GDMT) tailored to the unique challenges of this population. They will review how to evaluate and manage individuals where treatment decisions require balancing competing priorities and individualized care plans.
  • Disease management
  • Older adults
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
Activity descriptionThis activity focuses on the early recognition, prevention and management of sepsis and septic shock in long-term care settings, guided by the Surviving Sepsis Campaign: International Guidelines for Management of Sepsis 2021.
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 Attendance - General Attendance
  • 0.75 CCMC - General - Case Managers
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
This activity examines current data about chronic kidney disease (CKD), including its health outcomes and relationships with cardiovascular and metabolic disease. Treatment regimens aimed at delaying progression and their outcomes are reviewed, along with current knowledge regarding the pathophysiologic and genetic basis of this disease. Areas of emerging interest in research on potential new treatments targeting the causes of CKD are discussed, including genomic analysis, and their relevance to clinical care.

Pages